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Abstract
Background: The objectives of this study are to investigate the clinicopathological characteristics and prognosis
analysis of unicentric retroperitoneal Castleman’s disease (CD), and to improve the level of diagnosis and treatment
of unicentric retroperitoneal CD.
Methods: The clinical data of 14 patients with unicentric retroperitoneal CD undergoing surgery from September
2007 to March 2014 were retrospectively reviewed.
Results: There were six males and eight females with a median age of 39 years old (range 15–58). Only three
patients had a clinical manifestation of abdominal pain, and one patient associated with myasthenia gravis. All
patients underwent surgical resection. The mean operation time was 137 min with a range of 72–472 min. The
mean blood loss was 143 ml (range 50–500 ml). The CD was confirmed by histopathology. There were hyaline
vascular (HV) type of CD in 13 cases, and mixed type of CD in one case. The mean hospital stay was 17.9 days with a
mean postoperation hospital stay of 9.2 days. The duration of follow-up ranged from 21 to 99 months for 14 cases. All
the 14 patients were alive without recurrence.
Conclusions: Unicentric retroperitoneal CD is a rare disease that is often misdiagnosed due to the absence of
specific clinical manifestations. The final diagnosis depends on pathologic examination. Complete surgical resection of
the tumor is the best therapeutic alternative for unicentric CD.
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Background
Castleman’s disease (CD) was first described in 1956 by
Benjamin Castleman, who identified a series of patients
with solitary hyperplastic mediastinal lymph nodes
containing small, hyalinized follicles, and marked inter-
follicular vascular proliferation [1]. The etiology is un-
known, and it is characterized by the development of
tumorous masses of lymphoid tissue. Two clinical types
(unicentric and multicentric) have been subclassified
on histological forms: hyaline vascular (HV) type,
plasma cell (PC) type, and mixed type. As this disease
is rare and poorly understood, the optimal therapy is
unknown. This study was conducted to analyze the
clinicopathological characteristics and surgical treat-
ment for patients with unicentric retroperitoneal CD.
Methods
From September 2007 to October 2015, a total of 14
patients with unicentric retroperitoneal CD were man-
aged at our hospital. These patients were retrieved from
our pathology database, and the medical records were
reviewed for demographic data, clinical and patho-
logical characteristics. The extent of the disease was
assessed with the help of ultrasonography (US) and
computed tomography (CT) of the abdomen and rou-
tine blood chemistry analyses. The diagnosis of CD was
made based on the postoperative histological examin-
ation. Pathologically, hyaline vascular CD had hyaline
vascular follicles and interfollicular capillary prolifera-
tion. Plasma cell CD was characterized by follicular
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hyperplasia with intervening sheets of plasma cells. If
the features of both types were present, it was diag-
nosed as mixed type. The diagnosis of these types was
based on the criteria of Keller et al. [2].
The end-points were survival and recurrence. Follow-
up information was obtained. All patients were either
followed in our clinic or by telephone contact anywhere
possible until the time of the patients’ death or till the
end of this study. The duration of follow-up was de-
fined as the interval between diagnosis and the last
contact with each patient. Local recurrence was defined
as tumor relapse within the region of operative files.
Results
The study included all 14 cases of histologically con-
firmed CD at our hospital from September 2007 to
March 2014. The relevant clinical findings of all the 14
cases are summarized in (Table 1). Eight patients (57 %)
were female and six (43 %) were male, with a median age
of 39 years old and a range of 15–58 years. Ten patients
were asymptomatic, and masses were identified either
incidentally or by physical examination. Only three pa-
tients had a clinical manifestation of abdominal pain or
uncomfortable, and one patient associated with myas-
thenia gravis. The medical history and laboratory find-
ings of these patients were unremarkable. The tumor
marker of all cases, including CA-125, CA-19-9, CEA,
AFP, were normal. The tumor size determined by either
US or CT ranged from 3.0 × 2.5 × 1.8 to 7.0 × 7.5 ×
5.0 cm. In all the patients, the diagnosis of CD was con-
firmed after the resection and histological examination
of the specimen. Thirteen patients had HV type and
one patient had mixed type.
No patients were preoperatively suspected of CD,
but other diseases. No patients received any steroids
or immunotherapy because no one was suspected of
autoimmune diseases. All patients underwent surgical
resection. Preoperative biopsy for a definitive diagno-
sis was excluded in concern of the deep position and
the possibility of hemorrhea. Preoperation diagnosis
and surgical information are summarized in (Table 2).
The mean operation time was 137 min with a range of
72–472 min. The mean blood loss was 143 ml (range
50–500 ml). Three patients had a surgical approach of
laparoscopy. The two of them underwent laparoscopic
transperitoneal approach and the other one underwent
laparoscopic retroperitoneal approach. Distal pancrea-
tectomy was carried out unitedly in the two patients
because of a preoperation misdiagnosis of occupation
of pancreas. Only one patient received blood transfusion
and he was sent to intensive care unit (ICU) because of
massive hemorrhage. The reason of the other patient who
was also sent to ICU was postoperative myasthenic crisis.
The mean hospital stay was 17.9 days with a mean post-
operation hospital stay of 9.2 days. No patients received
chemotherapy or radiotherapy after surgical resection.
The mean duration of follow-up was 49.9 months
(range 21–99 months). All patients received US or CT
when they came back to clinic, and they no longer
showed symptoms or evidence of disease after surgical
resection within follow-up period. Incisional hernia
happened in one patient as a complication, and hydrops
in the operation area happened in two patients. No
other complications were found in all the patients. All
the patients had no need to take medicine of steroids
or received immunotherapy after operation.
Table 1 Patients and treatment, and survival in unicentric retroperitoneal CD
Patient (n) Age (years) Sex Histological type Treatment Hospital stay (days) Follow-up (months) Outcome
1 39 F HV CR 15 80 A-NED
2 30 M HV CR 20 61 A-NED
3 31 F HV CR 18 59 A-NED
4 15 F HV CR 13 46 A-NED
5 44 M HV CR 26 40 A-NED
6 58 F HV CR 12 40 A-NED
7 32 F HV CR 21 33 A-NED
8 40 M MIX CR 15 30 A-NED
9 39 F HV CR 9 26 A-NED
10 24 M HV CR 38 22 A-NED
11 52 M HV CR 23 20 A-NED
12 51 F HV CR 11 3 A-NED
13 29 M HV CR 14 2 A-NED
14 42 F HV CR 16 17 A-NED
A-NED alive and no evidence of disease, CR complete resection, F female, M male, HV hyaline vascular type, MIX mixed type
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Discussion
CD is a rare, nonneoplastic and lymphoproliferative dis-
order that can occur in any site where lymph nodes are
present, which is a rare diagnosis in departments all over
the world and remains detectable at relatively low levels.
Most commonly involved sites are the mediastinum
(60 %), retroperitoneum (11 %), and axilla (4 %) [3]. The
etiology of CD remains unclear, although several im-
munological mechanisms have been proposed, including
overproduction of IL-6 and human herpes virus type 8
infection [4]. Dysplastic or atypical follicular dendritic
cells positive for CD21 and CD35 have frequently been
described in the hyalinized center and also in the cy-
tology smears, and can even show monoclonality, yet
their role in the pathogenesis is unclear [5–7].
CD was divided into three subgroups based on its
histology, which were hyaline vascular type, plasma cell
type, and mixed type, and can be divided into two fur-
ther forms on the basis of clinical criteria: the more
common unicentric form and the less common multi-
centric form. The unicentric CD corresponds to the
hyaline vascular variant (> 90 %). Clinically, unicentric
CD tends to be present in the form of an enlarged, benign,
painless lymph node that generally remains asymptomatic
unless it begins to compress adjacent structures or is dis-
covered fortuitously at the time of a routine physical
examination, which occurs in young people and associated
with a benign clinical course. In the current literature, uni-
centric CD was asymptomatic in 31 % of patients and
symptomatic in 69 % of patients [8, 9], while 28.6 %
patients were found as associated symptoms in our pa-
tients with unicentric retroperitoneal CD. It is difficult
to differentiate CD from other tumors before patho-
logic diagnosis is confirmed. Some kinds of tumors
which located in the retroperitoneal region commonly
are listed in Table 3.
There is no definitive standard treatment regimen for
unicentric CD. This study illustrated that the standard
therapy of unicentric CD is surgical excision, which has
been proven to be curative upon complete resection
and en bloc. Complete surgical excision is the mainstay
of treatment and is virtually curative in all cases re-
ported thus far, with a 5-year survival rate approaching
100 % [2, 10]. Keller et al. reported that all their cases
of unicentric CD had an indolent clinical course and
mild biological behaviors, with the elimination of all
systemic symptoms after complete resection [2]. Bowne
et al. studied 16 cases of CD and reported that no clin-
ical or radiographic recurrence of symptoms was found
among the 8 of 16 cases of unicentric hyaline-vascular
disease patients who underwent complete surgical exci-
sion [9]. There are several reports that unicentric CD in
the abdominal cavity were treated laparoscopically [11,
12]. Some masses are well vascularized and adjacent to
the great vessels [11]; laparoscopy can offer magnified
images to facilitate and secure dissection. In our case
studies, all the 14 patients with unicentric retroperiton-
eal CD underwent a complete surgical resection, either
open or laparoscopy, and survived with excellent
prognosis.
Table 2 Preoperation diagnosis and surgical information










1 Occupation of pancreas 6 87 100 O-TA N 9
2 Occupation of hepatic
caudate lobe
6 105 150 O-TA N 10
3 Occupation of right adrenal 6 127 100 L-RA N 6
4 Ectopic pheochromocytoma 3 135 100 L-RA N 7
5 Retroperitoneal tumor 3 134 100 O-TA N 9
6 Occupation of pancreas 4.2 72 150 O-TA N 10
7 Retroperitoneal tumor 5.5 80 50 O-RA N 8
8 Retroperitoneal tumor 5.5 125 100 O-TA N 9
9 Retroperitoneal tumor 6 121 100 O-TA N 6
10 Occupation of pancreas 7.5 472 200 L-TA N 24
11 Occupation of right adrenal 7.5 159 500 O-TA Y 9
12 Retroperitoneal tumor 5.5 107 100 O-TA N 6
13 Retroperitoneal tumor 5 116 200 O-TA Y 7
14 Retroperitoneal tumor 4 80 50 O-TA N 9
O-TA open transperitoneal approach, O-RA open retroperitoneal approach, L-TA laparoscopic transperitoneal approach, L-RA laparoscopic retroperitoneal approach,
N no, Y yes, d day, ICU intensive care unit
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Conclusions
In conclusion, unicentric retroperitoneal CD is a rare
disease that is often misdiagnosed due to the nonspecific
clinical manifestations. The final diagnosis depends on
pathologic examination. Complete surgical resection of
the tumor, either laparotomy or laparoscopy, is the best
therapeutic alternative for unicentric CD.
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Table 3 Differential diagnosis
Clinical manifestations Pathological features
General features Microscopic features
Castleman’s disease Asymptomatic; may associated with
autoimmune diseases; divided into
unicentric type and multicentric type
Well-circumscribed, encapsulated mass,
reddish-brown
Divided into hyaline-vascular type,
plasma cell type and mixed type
Liposarcoma Deep, painless, gradually grew tumor Lobulated, multi-nodular, well defined Divided into well-differentiated type,
dedifferentiated type, myxoid type
and pleomorphic type
Pheochromocytoma High blood pressure, headaches,
palpitations, high metabolic state,
high blood sugar, sweating
Roundly, brown-yellow, internal
hemorrhage, necrosis or cystic
degeneration
Large irregular polygon cells, cells can
be stained by chromium salts
Metastasis tumor Different performances because of
different primary tumors, lack of specificity
Various Various
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